Accelerating drug discovery - from an inside to impact

AICURA’s drug repurposing platform identifies promising new uses for existing drugs, reducing time to market and lowering R&D costs. Our platform integrates real-world medical data, preclinical insights, and advanced AI to create a streamlined pathway from discovery to clinical validation.​

Preclinical

Data integration into AICURA's Data Layer

We integrate multimodal data to build Knowledge Graphs mapping complex relationships across drug targets, pathways, and diseases.
‍
​✓ 10+ open datasets containing drug, disease (including rare diseases), phenotype, proteins, genetics, and adverse events interactions
​✓ Proprietary clinical and pre-clinical datasets ​

Graph maps

Phase I

Drug-disease interaction mapping

Our AI System builds connections between existing drugs and potential new indications by:
‍
​✓ Mapping molecular pathways, drug-target interactions, and disease profiles​​
​✓ Identifying, predicting, and validating novel targets, biomarkers, and mechanisms of action (MoA)
✓ Ranking promising candidates based on biological plausibility and potential therapeutic impact​​

Imaging

Federated architecture

Data layer

Our platform

Screening & biomarkers

Phase II/III

Predictive modeling for treatment efficacy​

AI engine

Inclusion/exclusion criteria

Disease progression prediction

Safety prediction

Response prediction

With advanced AI modeling, we predict the effectiveness of repurposed drugs:
‍
​✓ Predictive algorithms assess treatment outcomes and safety profiles for each new indication​
​✓ Risk assessment tools de-risk clinical trials by using historical and real-world patient data​‍

Phase II/III

Data-driven trial design

AI engine

Inclusion/exclusion criteria

Disease progression prediction

Safety prediction

Response prediction

Our platform enhances clinical trial design for repurposed drugs by validating patient selection criteria and leveraging data-driven insights. Through comprehensive analysis, we identify optimal candidates for each repurposed drug while streamlining trial processes and optimizing study parameters to maximize the likelihood of regulatory approval.

Advantage in drug innovation beyond traditional development

AICURA's comprehensive AI platform is transforming traditional drug development by combining advanced data integration, intelligent disease mapping, and predictive modeling. Through our innovative approach to drug repurposing, we streamline the path from discovery to validation while significantly reducing development time and costs. Our platform empowers researchers and pharmaceutical companies to make data-driven decisions, optimize clinical trials, and ultimately bring life-changing treatments to patients faster and more efficiently than ever before.

What sets AICURA apart?

AICURA provides exclusive access to multimodal data and advanced AI Systems designed to accelerate and de-risk clinical programs. All of this is delivered within a secure and compliant federated infrastructure that prioritizes data integrity and patient privacy.

✓AI-ready multimodal data

Benefit from transformer-based architecture to handle the complexities of multimodal medical data, and scale rapidly across therapeutic areas. An intuitive user interface, combined with access to Jupyter Notebooks, allows easy visualization and analysis of all data.

✓ Easy-to-implement AI Systems

Take advantage of our workbench to rapidly deploy ready-to-use AI models, fine tuned on proprietary data even with limited labeling. Unlock next-generation insights and easily develop novel use cases.

✓ Federated and secure access

Leverage federated learning to protect data privacy and intellectual property while gaining insights across institutions. Our platform is built with the highest standards of safety and security to comply with strict data governance rules.